Log in

Sientra Stock Price, Forecast & Analysis (NASDAQ:SIEN)

$8.07
-0.46 (-5.39 %)
(As of 11/16/2019 08:00 AM ET)
Today's Range
$8.03
Now: $8.07
$8.65
50-Day Range
$5.72
MA: $6.74
$8.98
52-Week Range
$4.78
Now: $8.07
$19.38
Volume901,400 shs
Average Volume859,682 shs
Market Capitalization$399.30 million
P/E RatioN/A
Dividend YieldN/A
Beta0.24
Sientra, Inc, a medical aesthetics company, develops and sells medical aesthetics products to plastic surgeons in the United States. It operates through two segments, Breast Products and miraDry. The company offers silicone gel breast implants for use in breast augmentation and breast reconstruction procedures; breast tissue expanders; and scar management products under the Sientra, AlloX2, Dermaspan, Softspan, and BIOCORNEUM brand names. Read More…

Industry, Sector and Symbol

Industry Surgical appliances & supplies
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:SIEN
CUSIPN/A
Phone805-562-3500

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$68.13 million
Book Value$1.95 per share

Profitability

Net Income$-82,630,000.00
Net Margins-143.76%

Miscellaneous

Employees259
Market Cap$399.30 million
Next Earnings Date3/10/2020 (Estimated)
OptionableOptionable

Receive SIEN News and Ratings via Email

Sign-up to receive the latest news and ratings for SIEN and its competitors with MarketBeat's FREE daily newsletter.


Sientra (NASDAQ:SIEN) Frequently Asked Questions

What is Sientra's stock symbol?

Sientra trades on the NASDAQ under the ticker symbol "SIEN."

How were Sientra's earnings last quarter?

Sientra Inc (NASDAQ:SIEN) posted its quarterly earnings data on Thursday, November, 7th. The medical instruments supplier reported ($0.45) EPS for the quarter, beating analysts' consensus estimates of ($0.47) by $0.02. The medical instruments supplier had revenue of $22.41 million for the quarter, compared to analyst estimates of $20.05 million. Sientra had a negative return on equity of 122.95% and a negative net margin of 143.76%. The business's revenue for the quarter was up 32.8% compared to the same quarter last year. During the same quarter last year, the company earned ($0.72) earnings per share. View Sientra's Earnings History.

When is Sientra's next earnings date?

Sientra is scheduled to release their next quarterly earnings announcement on Tuesday, March 10th 2020. View Earnings Estimates for Sientra.

What price target have analysts set for SIEN?

8 Wall Street analysts have issued 1 year price objectives for Sientra's shares. Their forecasts range from $10.00 to $27.00. On average, they anticipate Sientra's share price to reach $15.75 in the next twelve months. This suggests a possible upside of 95.2% from the stock's current price. View Analyst Price Targets for Sientra.

What is the consensus analysts' recommendation for Sientra?

8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Sientra in the last year. There are currently 8 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Sientra.

Has Sientra been receiving favorable news coverage?

Media stories about SIEN stock have been trending extremely negative recently, InfoTrie Sentiment reports. The research firm rates the sentiment of news coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Sientra earned a news impact score of -5.0 on InfoTrie's scale. They also gave news stories about the medical instruments supplier a news buzz of 10.0 out of 10, indicating that recent news coverage is extremely likely to have an effect on the stock's share price in the next few days. View News Stories for Sientra.

Are investors shorting Sientra?

Sientra saw a drop in short interest in October. As of October 31st, there was short interest totalling 3,050,000 shares, a drop of 9.0% from the September 30th total of 3,350,000 shares. Based on an average trading volume of 803,200 shares, the short-interest ratio is currently 3.8 days. Approximately 7.1% of the shares of the company are sold short. View Sientra's Current Options Chain.

Who are some of Sientra's key competitors?

What other stocks do shareholders of Sientra own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Sientra investors own include Baidu (BIDU), Allergan (AGN), Regions Financial (RF), Oasis Petroleum (OAS), Verizon Communications (VZ), ChemoCentryx (CCXI), Genocea Biosciences (GNCA), Novavax (NVAX), Rigel Pharmaceuticals (RIGL) and Alibaba Group (BABA).

Who are Sientra's key executives?

Sientra's management team includes the folowing people:
  • Mr. Jeffrey M. Nugent, Chairman & CEO (Age 72)
  • Mr. Charles Huiner, COO and Sr. VP of Corp. Devel. & Strategy (Age 48)
  • Mr. Keith J. Sullivan, Director & Advisor to MiraDry Bus. (Age 61)
  • Mr. Paul Sean Little, CFO, Sr. VP & Treasurer (Age 54)
  • Ms. Deborah Bettencourt, VP of Customer Experience & Corp. Admin.

Who are Sientra's major shareholders?

Sientra's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include Granite Point Capital Management L.P. (1.15%), Assenagon Asset Management S.A. (0.57%), Monarch Partners Asset Management LLC (0.26%), Stephens Inc. AR (0.25%), Rhumbline Advisers (0.08%) and Bailard Inc. (0.04%). Company insiders that own Sientra stock include Jeffrey M Nugent, Keith J Sullivan, Patrick F Williams, Paul Sean Little, R Scott Greer and Timothy Haines. View Institutional Ownership Trends for Sientra.

Which major investors are selling Sientra stock?

SIEN stock was sold by a variety of institutional investors in the last quarter, including Granite Point Capital Management L.P., Stephens Inc. AR and Bailard Inc.. View Insider Buying and Selling for Sientra.

Which major investors are buying Sientra stock?

SIEN stock was bought by a variety of institutional investors in the last quarter, including Assenagon Asset Management S.A., Monarch Partners Asset Management LLC, Commonwealth Equity Services LLC and Rhumbline Advisers. Company insiders that have bought Sientra stock in the last two years include Jeffrey M Nugent, Keith J Sullivan, Patrick F Williams, Paul Sean Little, R Scott Greer and Timothy Haines. View Insider Buying and Selling for Sientra.

How do I buy shares of Sientra?

Shares of SIEN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Sientra's stock price today?

One share of SIEN stock can currently be purchased for approximately $8.07.

How big of a company is Sientra?

Sientra has a market capitalization of $399.30 million and generates $68.13 million in revenue each year. The medical instruments supplier earns $-82,630,000.00 in net income (profit) each year or ($3.25) on an earnings per share basis. Sientra employs 259 workers across the globe.View Additional Information About Sientra.

What is Sientra's official website?

The official website for Sientra is http://www.sientra.com/.

How can I contact Sientra?

Sientra's mailing address is 420 SOUTH FAIRVIEW AVENUE SUITE 200, SANTA BARBARA CA, 93117. The medical instruments supplier can be reached via phone at 805-562-3500 or via email at [email protected]


MarketBeat Community Rating for Sientra (NASDAQ SIEN)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  227 (Vote Outperform)
Underperform Votes:  275 (Vote Underperform)
Total Votes:  502
MarketBeat's community ratings are surveys of what our community members think about Sientra and other stocks. Vote "Outperform" if you believe SIEN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SIEN will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 11/17/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel